Search Results - "GAZIEV, DJAVID"
-
1
Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation
Published in Blood (01-08-1997)“…Abstract In thalassemia after successful bone marrow transplantation (BMT), iron overload remains an important cause of morbidity. After BMT, patients have…”
Get full text
Journal Article -
2
Bone Marrow Transplantation in Thalassemia: The Experience of Pesaro
Published in Annals of the New York Academy of Sciences (01-06-1998)“…: Early trials of allogenic bone marrow transplantation (BMT) for homozygous β thalassemia and the analyses of results of transplantation in patients under 17…”
Get full text
Journal Article -
3
Phlebotomy to Reduce Iron Overload in Patients Cured of Thalassemia by Bone Marrow Transplantation
Published in Blood (01-08-1997)“…In thalassemia after successful bone marrow transplantation (BMT), iron overload remains an important cause of morbidity. After BMT, patients have normal…”
Get full text
Journal Article -
4
Graft-versus-host disease after bone marrow transplantation for thalassemia : An analysis of incidence and risk factors
Published in Transplantation (27-03-1997)“…We analyzed risk factors in 724 patients evaluable for acute graft-versus-host disease (GVHD) and in 614 patients evaluable for chronic GVHD who had received…”
Get full text
Journal Article -
5
Novel approaches to the treatment of chronic graft-versus-host disease
Published in Expert opinion on investigational drugs (01-05-2001)“…Chronic graft-versus-host disease (cGvHD) continues to be the major problem in long-term survivors of allogeneic haematopoietic stem cell transplants and is…”
Get more information
Journal Article -
6
Treatment of Iron Overload in the "Ex-Thalassemic": Report from the Phlebotomy Program
Published in Annals of the New York Academy of Sciences (30-06-1998)“…After successful marrow transplantation (BMT) iron overload remains an important cause of morbidity in Thalassemia. After BMT, patients have normal…”
Get full text
Journal Article -
7
No Preferential Sensitivity of t(8;21) Acute Myeloid Leukemias to Cytosine Arabinoside in Vitro: Is Intensity of Therapy or High Dose Ara-C Crucial for Response?
Published in Leukemia & lymphoma (01-07-2004)“…Acute myeloid leukemia (AML) patients with core binding factor abnormalities [inv(16) or t(8;21)] have a relatively good prognosis, especially patients with…”
Get full text
Journal Article -
8
GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION FOR THALASSEMIA: AN ANALYSIS OF INCIDENCE AND RISK FACTORS1
Published in Transplantation (01-03-1997)Get full text
Journal Article -
9
Treatment of Iron Overload in the “Ex‐Thalassemic”: Report from the Phlebotomy Programa
Published in Annals of the New York Academy of Sciences (01-06-1998)“…: After successful marrow transplantation (BMT) iron overload remains an important cause of morbidity in Thalassemia. After BMT, patients have normal…”
Get full text
Journal Article